国产91情侣在线精品国产,老司机久久精品视频

Clofezone

NMR下載 COA and HPLC MSDS下載
names：
2-(4-chlorophenoxy)-N-(2-(diethylamino)ethyl)acetamide compound with 4-butyl-1,2-diphenylpyrazolidine-3,5-dione (11)
CAS號：
17449-96-6
MDL Number：
MF(分子式)： C33H41ClN4O4 MW(分子量)： 593.17
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

貨品編碼	規(guī)格	純度	價(jià)格 (￥)	現(xiàn)價(jià)(￥)	特價(jià)(￥)	庫存描述	數(shù)量	總計(jì) (￥)

大包裝詢價(jià) 提供各種包裝，敬請垂詢
收藏商品商品點(diǎn)評加入購物車立即購買

快速詢價(jià)

收起

你想詢價(jià)的產(chǎn)品

*產(chǎn)品名稱：

CAS號：

產(chǎn)品編號：

需求描述：

請準(zhǔn)確填寫您的聯(lián)系方式，以便為您提供最好的服務(wù)。

*公司名稱：

*電子郵箱：

聯(lián)系人：

*電話：

*驗(yàn)證碼：

詢價(jià)

中文別名	Clofezone
英文別名	Clofezone; Perclusone; Clofezonum
CAS號	17449-96-6
Inchi	InChI=1S/C19H20N2O2.C14H21ClN2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16;1-3-17(4-2)10-9-16-14(18)11-19-13-7-5-12(15)6-8-13/h4-13,17H,2-3,14H2,1H3;5-8H,3-4,9-11H2,1-2H3,(H,16,18)
InchiKey	ICBCZMIEENEERJ-UHFFFAOYSA-N
分子式 Formula	C33H41ClN4O4
分子量 Molecular Weight	593.17
溶解度Solubility
性狀	Solid powder
儲藏條件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

產(chǎn)品說明	Clofezone(CAS:17449-96-6):僅限應(yīng)用于工業(yè)或者科學(xué)研究過程中非醫(yī)療目的，不應(yīng)用于人類或動(dòng)物的臨床診斷以及治過程療，該產(chǎn)品非藥用，非食用。
Introduction	Clofezone, also known as Perclusone, is an analgesic and antipyretic with anti-inflammatory properties used in treatment of rheumatism.
Application1
Application2
Application3

警示圖
危險(xiǎn)性	Warning
危險(xiǎn)性警示
安全聲明
安全防護(hù)
備注

[1]Brackertz D. Comparison of clofezone and diclofenac in the treatment of out-patients suffering from activated (painful) osteoarthrosis. Z Rheumatol. 1978 Sep-Oct;37(9-10):342-9. PubMed PMID: 153679.

[2]Reinicke C, Helbing M, Klingenfeld U, Lasaroff I, Wessel G. [Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)]. Pharmazie. 1984 Dec;39(12):824-7. German. PubMed PMID: 6241720.

[3] Celik CM. [Experiences in the management of rheumatoid diseases using different clofezone doses]. Z Rheumatol. 1976 May-Jun;35(5-6):240-7. German. PubMed PMID: 133565.

[4] Tamura T. [Clofezone and oxyphenbutazone excluded from dental use]. Nihon Shika Ishikai Zasshi. 1984;37(4):391-5. Japanese. PubMed PMID: 6241218.

[5] Keitel W, Weber G, Hoffmann H. [Results of comparative clinical examinations of antirheumatics: clofezone, indomethacin, phenylbutazone]. Schweiz Rundsch Med Prax. 1971 Jan 5;60(1):18-21. German. PubMed PMID: 5313620.

6: David-Chaussé J, David-Chaussé F, Lagoarde J, Picot C. [Therapeutic study of an anti-inflammatory agent, Clofezone]. J Med Bord. 1967 Oct;144(10):1529-35. French. PubMed PMID: 5304355.7: Stroescu I, Stoicescu M, Dragomir M, Burtea A, Pintea G, Stoia I. [Value of clofezone in the treatment of rheumatic diseases]. Schweiz Rundsch Med Prax. 1971 Feb 16;60(7):217-20. French. PubMed PMID: 5555631.8: Machtey I. [Short term clofezone therapy in rheumatic diseases]. Harefuah. 1971 Jun 5;80(12):654-6. Hebrew. PubMed PMID: 5156431.9: Kaiser H. [Clofezone, a new potent antirheumatic drug]. Munch Med Wochenschr. 1973 Dec 7;115(49):2247-8. German. PubMed PMID: 4205416.10: Ogawa K, Oguchi J, Okada S. [Use of clofezone (pans) in oral surgery]. Shikai Tenbo. 1978;51(2):385-9. Japanese. PubMed PMID: 161230.1

對不起，暫無產(chǎn)品評價(jià)！

MSDS

SDS 1.0 中文

展開

SDS 1.0 英文

展開